What are the patient's current diagnoses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Diagnoses

Based on the clinical presentation provided, this patient has acute asthma exacerbation triggered by influenza-like illness (ILI) with concurrent acute bacterial sinusitis.

Primary Diagnoses

Acute Asthma Exacerbation

  • The patient presents with wheezing, dyspnea, and respiratory distress requiring hospitalization, which meets criteria for severe acute exacerbation of bronchial asthma 1
  • Viral respiratory infections, particularly influenza, are the predominant triggers that drive acute exacerbations of bronchial asthma, accounting for nearly 80% of exacerbation episodes 2, 3
  • The presence of fever >38°C, tachycardia >100 beats/min, tachypnea ≥24 breaths/min, and oxygen saturation concerns indicate clinical instability and severe illness 4
  • Patients with asthma who develop ILI are at higher risk for complications, with approximately one-third experiencing severe outcomes requiring ICU admission 5

Influenza-Like Illness (ILI)

  • Fever >38°C is the hallmark vital sign and diagnostic criterion for influenza-like illness requiring antiviral treatment 4
  • The patient meets criteria for ILI based on fever, respiratory symptoms, and systemic manifestations 4, 6
  • Early empiric antiviral therapy with oseltamivir should be initiated immediately in winter months for all severe asthma exacerbations where viral infection is suspected 2, 5
  • Delay in seeking medical care is associated with severe exacerbations (odds ratio 2.93), making early treatment critical 6

Acute Bacterial Sinusitis

  • The patient presents with sinus pressure, headache, and purulent nasal discharge persisting beyond 10-14 days, meeting criteria for acute bacterial sinusitis 1, 7, 8
  • Sinusitis that fails to improve after 21-28 days of initial antibiotic treatment may be caused by pathogens not adequately covered by prior antibiotics, presence of nasal polyps, or noncompliance 7
  • The combination of facial-dental pain, postnasal drainage, nasal congestion, and purulent secretions are hallmark symptoms of bacterial sinusitis 8

Secondary/Comorbid Diagnoses

Allergic Rhinitis

  • Consultation with an allergist-immunologist is appropriate when patients have comorbid conditions such as asthma and chronic sinusitis 1
  • Underlying allergic rhinitis should be evaluated as a risk factor contributing to recurrent sinusitis 1
  • The presence of nasal congestion, rhinorrhea, and postnasal drainage suggests concurrent allergic or non-allergic rhinitis 1

Possible Chronic Persistent Asthma

  • Classification of asthma severity requires assessment of impairment (symptoms, nighttime awakenings, SABA use, activity limitation) and risk (exacerbation frequency) 1
  • Patients requiring hospitalization for asthma exacerbation likely have at least moderate persistent asthma 1
  • Patients who had two or more exacerbations requiring oral systemic corticosteroids in the past year should be considered to have persistent asthma 1

Critical Management Implications

Immediate Treatment Requirements

  • Oxygen 40-60% should be administered immediately for all patients with severe asthma exacerbation 1
  • Nebulized salbutamol 5 mg or terbutaline 10 mg via oxygen-driven nebulizer should be given stat 1
  • Prednisolone 30-60 mg orally or intravenous hydrocortisone 200 mg should be administered 1
  • Empiric antibiotics with ceftriaxone and azithromycin, along with oseltamivir in winter months, should be initiated for all severe exacerbations where infection is suspected 2

Antibiotic Coverage for Sinusitis

  • High-dose amoxicillin-clavulanate (90 mg/kg amoxicillin and 6.4 mg/kg clavulanate, not to exceed 2 g every 12 hours) is recommended for treatment failure after initial therapy 1, 7
  • Treatment should continue for 10-14 days or until symptomatically improved to near normal 1, 7
  • Nasal corticosteroids should be added to reduce mucosal inflammation 7

Monitoring and Follow-up

  • Temperature, respiratory rate, pulse, blood pressure, mental status, and oxygen saturation should be monitored at least twice daily in hospitalized patients 4
  • Patients meeting two or more clinical instability criteria should remain hospitalized 4
  • Do not dismiss patients with normal vital signs if they have bilateral chest findings, as primary viral pneumonia can progress rapidly 4

Common Pitfalls to Avoid

  • Do not delay antiviral therapy - early treatment within 48 hours of symptom onset is associated with better outcomes and reduced severe complications 5
  • Do not underestimate the severity - patients with asthma and ILI may not report typical ILI symptoms but can still progress to severe exacerbation 6
  • Do not overlook co-infection - both viral and bacterial agents can play a role, and co-infection may worsen prognosis 2
  • Do not discontinue treatment prematurely - sinusitis requires full 10-14 day course even if symptoms improve earlier 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Infection in severe asthma exacerbations and critical asthma syndrome.

Clinical reviews in allergy & immunology, 2015

Guideline

Vital Signs in Influenza Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical characteristics of asthmatic patients with influenza-like illness and risk of severe exacerbations in Mexico.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016

Guideline

Management of Persistent Sinusitis After Three Weeks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Sinus Pressure and Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.